Concepedia

Homer L. Pearce

HL

17

Publications

1.6K

Citations

17

H-Index

1978

Active since

Affiliations

Eli Lilly (United States)(Current)

St. Jude Children's Research Hospital

Harvard University

Homer L. Pearce is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1978–2016

17

Publications

17

Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.

John M. Zamora, Homer L. Pearce, William T. Beck · Molecular Pharmacology · 1988 · 414 citations

Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study

Scott Weich, Homer L. Pearce, Peter Croft et al. · BMJ · 2014 · 246 citations · Full text

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.

Homer L. Pearce, Ahmad R. Safa, Nicholas J. Bach et al. · Proceedings of the National Academy of Sciences · 1989 · 234 citations · Full text

, , +18

Preclinical, pharmacologic, and phase I studies of gemcitabine.

Anna Maria Storniolo, Sandra R. B. Allerheiligen, Homer L. Pearce · PubMed · 1997 · 170 citations

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

Nanjoo Suh, Andrew L. Glasebrook, Alan D. Palkowitz et al. · PubMed · 2001 · 104 citations

, , +15

Rows per page

1–5 of 17